Author: Chatterjee, Victor; Yang, Xiaoyuan; Ma, Yonggang; Wu, Mack H.; Yuan, Sarah Y.
Title: Extracellular vesicles: new players in regulating vascular barrier function Cord-id: imdernzj Document date: 2020_12_1
ID: imdernzj
Snippet: Extracellular vesicles (EVs) have attracted rising interests in the cardiovascular field not only because they serve as serological markers for circulatory disorders but also because they participate in important physiological responses to stress and inflammation. In the circulation, these membranous vesicles are mainly derived from blood or vascular cells, and they carry cargos with distinct molecular signatures reflecting the origin and activation state of parent cells that produce them, thus
Document: Extracellular vesicles (EVs) have attracted rising interests in the cardiovascular field not only because they serve as serological markers for circulatory disorders but also because they participate in important physiological responses to stress and inflammation. In the circulation, these membranous vesicles are mainly derived from blood or vascular cells, and they carry cargos with distinct molecular signatures reflecting the origin and activation state of parent cells that produce them, thus providing a powerful tool for diagnosis and prognosis of pathological conditions. Functionally, circulating EVs mediate tissue-tissue communication by transporting bioactive cargos to local and distant sites, where they directly interact with target cells to alter their function. Recent evidence points to the critical contributions of EVs to the pathogenesis of vascular endothelial barrier dysfunction during inflammatory response to injury or infection. In this review, we provide a brief summary of the current knowledge on EV biology and advanced techniques in EV isolation and characterization. This is followed by a discussion focusing on the role and mechanisms of EVs in regulating blood-endothelium interactions and vascular permeability during inflammation. We conclude with a translational perspective on the diagnostic and therapeutic potential of EVs in vascular injury or infectious diseases, such as COVID-19.
Search related documents:
Co phrase search for related documents- acute infection and low toxicity: 1, 2, 3
- acute infection and lps induce: 1
- acute infection and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute infection and lung edema: 1, 2, 3, 4, 5, 6, 7
- acute infection and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- acute infection and lung kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- low toxicity and lps lipopolysaccharide: 1, 2
- low toxicity and lung edema: 1
- low toxicity and lung injury: 1, 2, 3
- low toxicity and lung kidney: 1
- lps induce acute lung injury and lung injury: 1
- lps induce acute lung injury and lung kidney: 1
- lps induce and lung edema: 1, 2
- lps induce and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- lps induce and lung kidney: 1
Co phrase search for related documents, hyperlinks ordered by date